|
MPP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21218615542784E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59179999958958E-07 |
| Normal-vs-Stage2 |
7.416700E-03 |
| Normal-vs-Stage3 |
2.357900E-03 |
| Normal-vs-Stage4 |
1.838170E-02 |
| Stage1-vs-Stage2 |
2.277200E-01 |
| Stage1-vs-Stage3 |
6.545200E-01 |
| Stage1-vs-Stage4 |
9.913600E-01 |
| Stage2-vs-Stage3 |
3.766400E-01 |
| Stage2-vs-Stage4 |
2.740000E-01 |
| Stage3-vs-Stage4 |
7.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4737988607294E-11 |
| Normal-vs-AfricanAmerican |
5.375600E-04 |
| Normal-vs-Asian |
1.232050E-01 |
| Caucasian-vs-AfricanAmerican |
5.223500E-03 |
| Caucasian-vs-Asian |
2.894200E-01 |
| AfricanAmerican-vs-Asian |
2.423400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41230035946671E-10 |
| Normal-vs-Female |
1.96340000002682E-06 |
| Male-vs-Female |
9.158100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.723500E-03 |
| Normal-vs-Extreme_Weight |
1.19700000000833E-06 |
| Normal-vs-Obese |
6.372900E-04 |
| Normal-vs-Extreme_Obese |
6.217700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.778800E-01 |
| Normal_Weight-vs-Obese |
9.768200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.038200E-01 |
| Extreme_Weight-vs-Obese |
6.257200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.422400E-01 |
| Obese-vs-Extreme_Obese |
7.625000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.102340E-02 |
| Normal-vs-Age(41-60Yrs) |
5.58199999556308E-08 |
| Normal-vs-Age(61-80Yrs) |
1.20239999956695E-07 |
| Normal-vs-Age(81-100Yrs) |
7.823800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.038800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.848800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.058400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.196200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.854400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.067200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.92580001629517E-09 |
| Normal-VS-Type2 PRCC |
1.25959999996983E-06 |
| Normal-VS-KIRP CIMP |
4.536800E-03 |
| Normal-VS-Unclassified PRCC |
2.960500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.786100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.941000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.856800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.118570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.716440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.079200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.645900E-04 |
| Normal-vs-N1 |
4.995900E-03 |
| Normal-vs-N2 |
3.371400E-01 |
| N0-vs-N1 |
7.789200E-01 |
| N0-vs-N2 |
6.077000E-01 |
| N1-vs-N2 |
6.542400E-01 |
|
|
